Edwards Lifesciences Corporatio vs Merck & Company, Inc. — Stock Comparison

EW
Edwards Lifesciences Corporatio
$83.98
▲ 0.57%
vs
MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
Q·Score Winner
Edwards Lifesciences Corporatio
EW7.2/10vs 6.7/10

Q·Score Breakdown

7.2
Bullish
Overall
6.7
Neutral
6.2
Quality
6.2
8
Health
7
7.3
Growth
6.2
7
Valuation
7.2
7.6
Sentiment
7.1
EW

Clean balance sheet with low leverage (0.1× debt-to-equity).

MRK

Forward P/E of 11.5× is low relative to sector peers.

Analyst Consensus

BUY
Target $97.15 (+15.7%)
27 analysts
BUY
Target $129.74 (+15.7%)
27 analysts

Fundamentals

EW
MRK
45.4×
Trailing P/E
31.5×
25.0×
Forward P/E
11.5×
17.4%
Profit Margin
13.6%
77.9%
Gross Margin
76.6%
ROE
16.7%
Revenue Growth
4.9%
8.2%
Earnings Growth
0.94
Beta
0.28
Price / Book
$48.4B
Market Cap
$277.0B
$72 – $88
52-Week Range
$73 – $125

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →